Literature DB >> 23664508

DNA methylation and primary immune thrombocytopenia.

Huiyuan Li1, Min Xuan, Renchi Yang.   

Abstract

DNA methylation is a heritable, stable, and also reversible way of DNA modification; it can regulate gene expression without changing the nucleotide sequences. Because it takes part in regulation of immune responses, the loss of methylation homeostasis in immune cells will result in autoimmune disease by inducing aberrant gene expression. Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease with many immune deficiencies. Recently, it was well documented that abnormal DNA methylation is also involved in the etiology of ITP. In this review, we elucidate the role of DNA methylation in autoimmune diseases by summarizing the DNA methylation-sensitive genes and the relationship between DNA methylation and ITP.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23664508     DOI: 10.1053/j.seminhematol.2013.03.022

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  2 in total

1.  Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia.

Authors:  Panpan Han; Tianshu Yu; Yu Hou; Yajing Zhao; Yang Liu; Yunqi Sun; Haoyi Wang; Pengcheng Xu; Guosheng Li; Tao Sun; Xiang Hu; Xinguang Liu; Lizhen Li; Jun Peng; Hai Zhou; Ming Hou
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

2.  Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia.

Authors:  Panpan Han; Yu Hou; Yajing Zhao; Yang Liu; Tianshu Yu; Yunqi Sun; Haoyi Wang; Pengcheng Xu; Guosheng Li; Tao Sun; Xiang Hu; Xinguang Liu; Lizhen Li; Jun Peng; Hai Zhou; Ming Hou
Journal:  Blood       Date:  2021-08-26       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.